Page last updated: 2024-08-21

sorbitan monostearate and Prostatic Neoplasms

sorbitan monostearate has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alemi, A; Farrokhifar, M; Haghi Karamallah, M; Hamidieh, AA; Hosseini, SA; Soltaninejad, H; Taheri-Kafrani, A; Zare-Zardini, H	1

Other Studies

1 other study(ies) available for sorbitan monostearate and Prostatic Neoplasms

Article	Year
Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study. Drug design, development and therapy, 2020, Volume: 14 Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Cholesterol; Drug Compounding; Drug Liberation; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Fatty Acids, Monounsaturated; Ginsenosides; Hexoses; Humans; Liposomes; Male; Panax; Particle Size; PC-3 Cells; Prostatic Neoplasms; Quaternary Ammonium Compounds; Tumor Cells, Cultured	2020

Article

Year

Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.

Drug design, development and therapy, 2020, Volume: 14

Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Cholesterol; Drug Compounding; Drug Liberation; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Fatty Acids, Monounsaturated; Ginsenosides; Hexoses; Humans; Liposomes; Male; Panax; Particle Size; PC-3 Cells; Prostatic Neoplasms; Quaternary Ammonium Compounds; Tumor Cells, Cultured

2020